Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Brunmair 2004 Diabetes

From Bioblast
Revision as of 02:23, 12 February 2020 by Gnaiger Erich (talk | contribs)
Publications in the MiPMap
Brunmair B, Staniek K, Gras F, Scharf N, Althaym A, Clara R, Roden M, Gnaiger E, Nohl H, Waldhäusl W, Fürnsinn C (2004) Thiazolidinediones, like metformin, inhibit respiratory Complex I: a common mechanism contributing to their antidiabetic actions? Diabetes 53:1052-9.

» PMID: 15047621 Open Access

Brunmair B, Staniek K, Gras F, Scharf N, Althaym A, Clara R, Roden M, Gnaiger E, Nohl H, Waldhaeusl W, Fuernsinn C (2004) Diabetes

Abstract: Metformin and thiazolidinediones (TZDs) are believed to exert their antidiabetic effects via different mechanisms. As evidence suggests that both impair cell respiration in vitro, this study compared their effects on mitochondrial functions. The activity of Complex I of the respiratory chain, which is known to be affected by metformin, was measured in tissue homogenates that contained disrupted mitochondria. In homogenates of skeletal muscle, metformin and TZDs reduced the activity of Complex I (30 mmol/L metformin, -15 +/- 2 %; 100 µmol/L rosiglitazone, -54 +/- 7; and 100 µmol/L pioglitazone, -12 +/- 4; P < 0.05 each). Inhibition of Complex I was confirmed by reduced State 3 respiration of isolated mitochondria consuming glutamate + malate as substrates for Complex I (30 mmol/L metformin, -77 +/- 1 %; 100 µmol/l rosiglitazone, -24 +/- 4; and 100 µmol/l pioglitazone, -18 +/- 5; P < 0.05 each), whereas respiration with succinate feeding into Complex II was unaffected. In line with inhibition of Complex I, 24-h exposure of isolated rat soleus muscle to metformin or TZDs reduced cell respiration and increased anaerobic glycolysis (glucose oxidation: 270 µmol/L metformin, -30 +/- 9 %; 9 µmol/L rosiglitazone, -25 +/- 8; and 9 µmol/L pioglitazone, -45 +/- 3; lactate release: 270 µmol/L metformin, +84 +/- 12; 9 µmol/L rosiglitazone, +38 +/- 6; and 9 µmol/L pioglitazone, +64 +/- 11; P < 0.05 each). As both metformin and TZDs inhibit Complex I activity and cell respiration in vitro, similar mitochondrial actions could contribute to their antidiabetic effects.

Bioblast editor: Gnaiger E


Labels: MiParea: Respiration, Pharmacology;toxicology  Pathology: Diabetes 

Organism: Rat  Tissue;cell: Skeletal muscle, Liver  Preparation: Intact organ, Isolated mitochondria  Enzyme: Complex I  Regulation: Coupling efficiency;uncoupling  Coupling state: LEAK, OXPHOS  Pathway: N, S 


Metformin